Search

Objectives Cognitive and emotional disturbances have been associated with the diagnosis and treatment of cancer. Autobiographical memory is one of the specific cognitive processes affected during this disease. The current study had two main aims: (1) to compare the functioning of autobiographical memory specificity and its related variables (executive functioning, depression and perceived stress) in a group of persons with cancer and a control group; and (2) to analyze whether the experience of cancer evolved into a self-defining memory in the sample of participants diagnosed with this disease. Method The study sample comprised 62 participants, 31 in the group with a cancer diagnosis and 31 in the control group. Autobiographical memory specificity, executive functions, depression, stress and self-defining memory were evaluated in the current study. Results Depressive symptomatology and reduced executive functioning, but not perceived stress levels, are related and are predictors of autobiographical memory specificity. In addition, the identified characteristics of the self-defining memories were associated with the cancer experience as a threat to physical integrity and an awareness of the meaning of life. Conclusion This emerging research line is especially important in view of its possible impacts on patients’ well-being, due to the importance of psychological processes in cancer disease.

Resumen Introduccion Estimar la prevalencia del consumo de ansioliticos e hipnoticos referido por los mayores de 65 anos e identificar posibles factores condicionantes del citado uso. Material y metodos Estudio transversal. La poblacion de estudio fue de 1.161 sujetos de ≥65 anos no institucionalizados con suficiente capacidad para llevar a cabo una entrevista personal. Seleccion mediante muestreo aleatorizado simple del listado de tarjeta sanitaria. Las principales variables evaluadas incluyeron: consumo referido de ansioliticos/hipnoticos y otros farmacos (segun el sistema de clasificacion ATC), estado animico (GDS-VE), estado cognitivo (cuestionario Pfeiffer), valoracion fisica-funcional sobre actividades basicas de la vida diaria (indice de Katz), problemas de salud (clasificacion CIAP-2 de la WONCA) y variables sociodemograficas. Resultados La prevalencia de uso referido de ansioliticos/hipnoticos fue del 16,6% (IC 95%: 14,5-18,7). El 90,5% fueron benzodiacepinas (BZD), fundamentalmente lorazepam (39,4% de las BZD). Las BZD de vida media prolongada supusieron el 24,7% de todas. Los hipnoticos representaron el 27,5% de los ansioliticos/hipnoticos. El uso de ansioliticos/hipnoticos se asocio independientemente con consumir otros farmacos no psicotropicos (OR: 6,8; IC 95%: 2,1-22,0), presentar depresion establecida (OR: 2,5; IC 95%: 1,0-5,9), presentar 4 o mas problemas de salud (OR: 2,0; IC 95%: 1,4-2,9), ser mujer (OR: 2,1; IC 95%: 1,5-3,1) y ser dependiente para las actividades basicas de la vida diaria (OR: 1,8; IC 95%: 1,1-2,9). Conclusiones La prevalencia de uso de ansioliticos/hipnoticos es elevada en mayores de Albacete. Diversos factores han sido identificados como potenciales condicionantes de su utilizacion. Seria importante mejorar el conocimiento sobre el mal uso de estos farmacos con el fin de desarrollar estrategias de prescripcion efectivas y seguras.

Objective: The aims of this study were to determine the true frequency of primary insomnia (PI), sleep disorder related to another mental disorder (SDMD) and sleep disorder due to a general medical condition (SDMC) in older adults and to establish their differentiating characteristics. Methods: This is a cross-sectional study. Participants were randomly selected samples of 951 subjects who are 65 years or older. Main measures were as follows: presence (according to DSM-IV-TR diagnostic criteria) of PI, SDMD, SDMC or other sleep disorders, co-morbidity and psychotropic consumption. Results: Of the subjects, 36.1% reported having sleep problems (95%CI:33.0–39.2) and 37.0% reported regularly consuming a psychotropic drug. The prevalence of PI was 8.9% (95%CI: 7.1–11.0), and according to the criteria for differential diagnosis, the prevalence of SDMD was 9.3% (95%CI: 7.5–11.4) and that of SDMC was 7.0% (95%CI: 5.4–8.9). A higher percentage of PI subjects had problems in falling asleep on most days (52.5%), had frequent night-time awakenings (66.3%) and early awakenings (51.3%). In subjects with any type of insomnia, the variables that showed a statistically significant association were female gender (OR: 2.21), consumption of psychotropic drugs (OR: 1.83), presence of four or more health problems (OR: 1.88) and being single, widowed or divorced (OR: 1.43). Conclusions: Our results provide a true picture of the prevalence of insomnia in older adults on the basis of diagnostic criteria and indicate that it is a widespread, significant health problem. The peculiarities of PI, SDMD and SDMC need to be appropriately differentiated in clinical practice, and each needs a different approach to obtain the best outcome. Copyright © 2011 John Wiley & Sons, Ltd.

ResumenObjetivosEstablecer la prevalencia y las características del insomnio y su relación con otros problemas de salud, consumo de fármacos, situación sociosanitaria y hábitos higiénicos en mayores de 65 años.DiseñoEstudio de prevalencia y asociación cruzada.EmplazamientoAlbacete (Castilla-La Mancha), 2004–2005.ParticipantesPoblación mayor de 65 años no institucionalizada (n=424).MétodoEntrevista semiestructurada. Variables de estudio: características del sueño, repercusiones sociofamiliares, hábitos higiénicos del sueño, problemas de salud, medicación, utilización de servicios sanitarios y variables sociodemográficas. Insomnio primario (IP) diagnosticado con criterios DSM-IV.ResultadosDeclaró problemas para dormir el 34,2%; en el 95,7% la alteración era crónica. La repercusión más frecuente fue sensación de descanso nocturno insuficiente (62,1%) y cansancio o somnolencia diurna (52,2%). El 20,3% (intervalo de confianza [IC] del 95%, 16,5–24,1) cumplía criterios de IP. El insomnio fue mayor en las mujeres, en los que tenían horarios irregulares e insatisfacción con las condiciones ambientales del dormitorio. El 26,9% (IC del 95%, 22,7–31,1) consumía de forma habitual psicofármacos. El número medio de problemas de salud fue superior en sujetos con insomnio (2,4±1,6 frente a 1,7±1,5; p

The objective is to determine the prevalence of hearing loss in people over 65 years of age, to describe the functional status of people with hearing loss and to identify the need for hearing aid use. In a cross-sectional study, a random sample of 1387 people aged 65 years and over was selected. The primary study variables were: hearing level by audiometric assessment, self-perceived hearing loss, screening for hypoacusia using the Hearing Handicap Inventory for the Elderly-Screening (HHIE-S) and physical, cognitive and emotional functional status. Using the HHIE-S it was determined that 11.3% of the subjects had severe hearing handicap. According to the Ventry/Weinstein criteria 43.6% had hearing handicap. When asked about the use of hearing aids, 4.5% of the study subjects said they used them, although 41.9% had hearing loss of 35 dB or more in their better ear. The variables associated with the need for a hearing aid were age >75 years (odds ratio=OR=3.2), ADL dependence (OR=2.7), cognitive impairment (OR=2.0), multiple health problems (OR=1.8), male sex (OR=1.6) and single/widowed (OR=1.5). In conclusion, there is a high prevalence of hearing loss associated with other functional limitations. Of those people who would benefit from a hearing aid (more than a third of people over 65 years old), 89.3% do not own one. The screening of hearing loss needs to be improved.

To estimate the prevalence of self-reported anxiety/hypnotics use in adults 65 years and older and identify potential factors that determine the use of these drugs.Cross-sectional study conducted on a study population of 1,161 non-institutionalised adults 65 years old and older with enough ability to conduct a personal interview. Participants were randomly selected from health care registers. The main outcomes of interest included consumption of anxiolytics, hypnotics and other drugs (filed by ATC classification system), mood (based on the Yesavage geriatric depression scale), cognitive status (Pfeiffer questionnaire), physical-functional assessment of basic activities of daily living (Katz index), health problems (ICPC-2 classification WONCA), and sociodemographic variables.The prevalence of self-reported anxiety/hypnotics consumption was 16.6% (95% CI: 14.5 - 18.7), of which 90.5% were benzodiazepines (BZD), mainly lorazepam (39.4% of BZD). Long half-life BZD accounted for 24.7% of BZD. Hypnotics accounted for 27.5% of anxiolytics/hypnotics. The use of sedatives/hypnotics was independently associated with other drugs (non-psychotropics) consumption (OR 6.8, 95% CI: 2.1-22.0), presence of established depression (OR: 2.5; 95% CI: 1.0 -5.9), presence of 4 or more comorbidities (OR: 2.0; 95% CI: 1.4-2.9), being female (OR 2.1, 95% CI: 1.5-3.1) and being dependent for basic activities of daily living (OR: 1.8, 95% CI: 1.1-2.9).The prevalence of sedatives/hypnotics use in the elderly from Albacete is high. Several factors were identified as potential determinants of sedatives/hypnotics use in our study population. It will be important to evaluate the misuse of these drugs in order to develop effective, efficient and safe prescription strategies.

The aims of this study were to determine the true frequency of primary insomnia (PI), sleep disorder related to another mental disorder (SDMD) and sleep disorder due to a general medical condition (SDMC) in older adults and to establish their differentiating characteristics.This is a cross-sectional study. Participants were randomly selected samples of 951 subjects who are 65 years or older. Main measures were as follows: presence (according to DSM-IV-TR diagnostic criteria) of PI, SDMD, SDMC or other sleep disorders, co-morbidity and psychotropic consumption.Of the subjects, 36.1% reported having sleep problems (95% CI: 33.0-39.2) and 37.0% reported regularly consuming a psychotropic drug. The prevalence of PI was 8.9% (95% CI: 7.1-11.0), and according to the criteria for differential diagnosis, the prevalence of SDMD was 9.3% (95% CI: 7.5-11.4) and that of SDMC was 7.0% (95%CI: 5.4-8.9). A higher percentage of PI subjects had problems in falling asleep on most days (52.5%), had frequent night-time awakenings (66.3%) and early awakenings (51.3%). In subjects with any type of insomnia, the variables that showed a statistically significant association were female gender (OR: 2.21), consumption of psychotropic drugs (OR: 1.83), presence of four or more health problems (OR: 1.88) and being single, widowed or divorced (OR: 1.43).Our results provide a true picture of the prevalence of insomnia in older adults on the basis of diagnostic criteria and indicate that it is a widespread, significant health problem. The peculiarities of PI, SDMD and SDMC need to be appropriately differentiated in clinical practice, and each needs a different approach to obtain the best outcome.

En los meses de abril, julio y agosto de 2010, los autores de este artículo nos marcamos como objetivo conocer de primera mano la atención primaria en el Nacional Health Service (NHS). Así pues, la experiencia de participación activa de cada uno de nosotros en un modelo referente en atención primaria responde a una fuerte motivación personal, suponiendo un especial atractivo para la configuración de este artículo el poder extrapolar nuestras apreciaciones e impresiones, claramente marcadas por los diferentes momentos de nuestra trayectoria profesional en la valoración de las diferencias estructurales, organizativas, de los lugares de trabajo, del análisis de los equipos, de la formación y de la figura del que hoy por hoy es el principal protagonista de un modelo de salud pionero en Europa.

PURPOSE We wanted to design and validate the Hearing-Dependent Daily Activities (HDDA) Scale as a means of identifying the impact of hearing loss in older persons by measuring capacity to carry out hearing-dependent activities. METHODS We undertook a cross-sectional, observational study to validate a scale administered during a personal interview with 1,160 participants aged 65 years and older. When using the instrument to identify patients with hearing impairment, sensitivity and specificity were determined using an audiogram with Ventry and Weinstein criteria as the criterion standard. Standardized audiometries were performed blindly, without knowledge of results of the HDDA Scale. RESULTS According to the criterion standard, 506 participants had hearing impairment (43.6%; 95% confidence interval [CI], 40.8%–46.5%). The HDDA scale showed high internal consistency (Cronbach’s α =0.91). Regarding hearing impairment criteria, the HDDA scale obtained a sensitivity of 80.0% (95% CI, 76.3%–83.3%) and a specificity of 70.2% (95% CI, 66.5%–73.5%). CONCLUSIONS The HDDA scale constitutes a clinically useful instrument for identifying the impact of hearing loss on daily life in the elderly, a condition frequently overlooked during routine medical check-ups. This tool has acceptable psychometric properties and high internal consistency.

Insomnia causes psychological distress in the elderly. Besides primary insomnia (PI), illness, medications and psychosocial factors contribute to development of sleep disorders. Although elderly insomniacs usually complain of poorer daytime functioning, it is unknown whether the disorder affects capacity to carry out activities. To assess the relationship in the elderly between PI, level of physical functioning, depression and anxiety symptoms, state of psychological well-being and consumption of psychopharmaceuticals. Cross-sectional, observational study. Populational. About 424 non-institutionalized elderly patients. Subjects were interviewed at public Health Centres or at home. They were considered to have PI if DSM-IV criteria were met. The remaining variables measured were: depression and anxiety symptoms (The Goldberg’s Depression and Anxiety Scale), cognitive state (Short Portable Mental Status Questionnaire), physical functioning (The Katz Index and the Instrumental Activities of Daily Living Scale), life satisfaction (The Philadelphia Geriatric Center Morale Scale), health problems, consumption of pharmaceuticals and sociodemographic variables. About 34.2% of the elderly admitted to having problems with sleep, but only 20.3% (CI: 95%: 16.5–24.1) fulfilled the criteria for PI. The existence of an anxiety disorder, a score below the 50th percentile on The Philadelphia Geriatric Center Morale Scale (lower life satisfaction) and consumption of psychopharmaceuticals were variables associated with insomnia. Amongst the most common illnesses reported, only diabetes appeared with significantly higher frequency in the elderly with insomnia (24.4% vs. 14.7%) (p < 0.05). No statistically significant association was found between insomnia and level of dependence in carrying out basic or instrumental activities. Approximately one fifth of the non-institutionalized elderly meet the criteria for PI. Those affected present a poorer state of psychological and social well-being, although level of autonomy for conducting basic and instrumental activities does not appear to be modified by the disorder. The existence of an anxiety disorder, low life satisfaction and consumption of psychopharmaceuticals constitute variables associated with PI in the population we studied.